US BANCORP \DE\

Bank

Position in CVM — Cel Sci Corp

CIK 36104 MINNEAPOLIS, MN

Position in CVM

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$31,103

-$64,898 QoQ

Shares Held

29,907

0.0% QoQ

Ownership

0.170%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#14

of 41 holders

Holding Since

Sep 2020

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

US BANCORP \DE\ holds $82,066,335 across 213 Biotechnology names. CVM ranks #95 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	AXSM	Axsome Therapeutics, Inc.	66,580	$16,296,786
2	VRTX	Vertex Pharmaceuticals Inc / Ma	32,020	$15,905,293
3	TECH	BIO-TECHNE Corp	137,966	$9,747,297
4	REGN	Regeneron Pharmaceuticals, Inc.	5,330	$3,323,466
5	ARGX	Argenx SE	3,495	$3,242,555
6	ARWR	Arrowhead Pharmaceuticals, Inc.	38,226	$3,115,799
7	JAZZ	Jazz Pharmaceuticals plc	10,103	$2,434,518
8	GMAB	Genmab A/S	88,420	$2,428,896

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,103	29,907	0.0%	Shares	Defined	2026-08-12
2026-03-31	$96,001	29,907	+62.4%	Shares	Defined	2026-05-15
2025-12-31	$96,852	18,413	+111.8%	Shares	Defined	2026-01-30
2025-09-30	$79,994	8,695	+869400.0%	Shares	Defined	2025-11-12
2024-06-30	$1	1	-100.0%	Shares	Defined	2024-08-07
2024-03-31	$19,021	9,959	+130.1%	Shares	Defined	2024-05-08
2023-12-31	$11,774	4,329	+2805.4%	Shares	Defined	2024-02-09
2021-09-30	$1,637	149	-89.9%	Shares	Defined	2021-11-10
2021-06-30	$12,768	1,471	+6.1%	Shares	Defined	2021-08-05
2021-03-31	$21,096	1,387	+47.2%	Shares	Defined	2021-04-28
2020-12-31	$10,983	942	+135.5%	Shares	Defined	2021-02-04
2020-09-30	$5,099	400	—	Shares	Defined	2020-11-10
No filing history on record for this holder in this stock.